Normal alpha olefin synthesis using dehydroformylation or dehydroxymethylation
US-10723672-B2 · Jul 28, 2020 · US
US11072569B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11072569-B2 |
| Application number | US-202016920835-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 6, 2020 |
| Priority date | Feb 26, 2018 |
| Publication date | Jul 27, 2021 |
| Grant date | Jul 27, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses processes for producing normal alpha olefins, such as 1-hexene, 1-octene, 1-decene, and 1-dodecene in a multistep synthesis scheme from another normal alpha olefin. Also disclosed are reactions for converting aldehydes, primary alcohols, and terminal vicinal diols into normal alpha olefins.
Opening claim text (preview).
What is claimed is: 1. A process comprising: (i) conducting a dihydroxylation reaction of a first normal alpha olefin having the structure CH 3 (CH 2 ) n HC═CH 2 to form a terminal vicinal diol having the structure CH 3 (CH 2 ) n CH(OH)CH 2 OH; and (ii) contacting the terminal vicinal diol with a catalyst composition to form a second normal alpha olefin having the structure CH 3 (CH 2 ) n−2 HC═CH 2 ; wherein n is an integer from 2 to 33; and wherein the catalyst composition comprises: (I) a transition metal compound, a phosphine, and a heteroatomic acid or heteroatomic acid derivative; or (II) a phosphine transition metal compound complex and a heteroatomic acid or heteroatomic acid derivative. 2. The process of claim 1 , wherein: the second normal alpha olefin comprises 1-hexene, 1-octene, 1-decene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1-octadecene, or any combination thereof; the transition metal compound or the transition metal compound of the phosphine transition metal compound complex comprises an olefin rhodium alkoxide complex; and the heteroatomic acid or heteroatomic acid derivative comprises a carboxylic acid, an alcohol, a mineral acid, an ammonium salt, an amine, a thiol, or any combination thereof. 3. The process of claim 2 , wherein: a molar ratio of the vicinal diol to the transition metal of the transition metal compound or the phosphine transition metal compound complex is in a range from about 2:1 to about 1000:1; and the heteroatomic acid or heteroatomic acid derivative comprises benzoic acid or a substituted benzoic acid, or a salt or ester of benzoic acid or a substituted benzoic acid. 4. The process of claim 1 , wherein the catalyst composition further comprises an acceptor. 5. The process of claim 3 , wherein the acceptor comprises an enone, an enamine, an enol, an enamide, or any combinations thereof. 6. The process of claim 3 , wherein: the second normal alpha olefin comprises 1-hexene, 1-octene, 1-decene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1-octadecene, or any combination thereof; and a molar ratio of the acceptor to the vicinal diol is in a range from about 0.2:1 to about 1000:1. 7. The process of claim 6 , wherein a molar yield of the second normal alpha olefin is at least about 50%, based on the vicinal diol. 8. The process of claim 6 , wherein: the transition metal compound or the transition metal compound of the phosphine transition metal compound complex comprises an olefin rhodium alkoxide complex; and the heteroatomic acid or heteroatomic acid derivative comprises a carboxylic acid, an alcohol, a mineral acid, an ammonium salt, an amine, a thiol, or any combination thereof. 9. The process of claim 8 , wherein: the heteroatomic acid or heteroatomic acid derivative comprises benzoic acid or a substituted benzoic acid, or a salt or ester of benzoic acid or a substituted benzoic acid. 10. A process comprising: (i) contacting a first normal alpha olefin having the structure CH 3 (CH 2 ) n HC═CH 2 and a metathesis catalyst system to form a linear internal olefin having the structure CH 3 (CH 2 ) n HC═CH(CH 2 ) n CH 3 ; (ii) contacting the linear internal olefin with a hydroformylation catalyst system, carbon monoxide, and hydrogen to form a linear aldehyde having the formula CH 3 (CH 2 ) 2n+3 C(═O)H; and (iii) contacting the linear aldehyde with a catalyst composition to form a second normal alpha olefin having the structure CH 3 (CH 2 ) 2n+1 HC═CH 2 ; wherein n is an integer from 0 to 15; and wherein the catalyst composition comprises: (I) a transition metal compound, a phosphine, a heteroatomic acid or heteroatomic acid derivative, and an acceptor; or (II) a phosphine transition metal compound complex, a heteroatomic acid or heteroatomic acid derivative, and an acceptor. 11. The process of claim 10 , wherein: the second normal alpha olefin comprises 1-hexene, 1-octene, 1-decene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1-octadecene, or any combination thereof; and a molar ratio of the acceptor to the linear aldehyde is in a range from about 0.2:1 to about 1000:1. 12. The process of claim 11 , wherein the acceptor comprises an enone, an enamine, an enol, an enamide, or any combinations thereof. 13. The process of claim 11 , wherein: a molar yield of the second normal alpha olefin is at least about 50%, based on the linear aldehyde; the transition metal compound or the transition metal compound of the phosphine transition metal compound complex comprises an olefin rhodium alkoxide complex; and the heteroatomic acid or heteroatomic acid derivative comprises a carboxylic acid, an alcohol, a mineral acid, an ammonium salt, an amine, a thiol, or any combination thereof. 14. The process of claim 11 , wherein: the heteroatomic acid or heteroatomic acid derivative comprises benzoic acid or a substituted benzoic acid, or a salt or ester of benzoic acid or a substituted benzoic acid. 15. A process comprising: (a) contacting a linear internal olefin having the structure CH 3 (CH 2 ) p HC═CH(CH 2 ) q CH 3 with a hydroformylation catalyst system, carbon monoxide, and hydrogen to form a linear aldehyde having the formula CH 3 (CH 2 ) p+q+3 C(═O)H; and (b) contacting the linear aldehyde with a catalyst composition to form a normal alpha olefin having the structure CH 3 (CH 2 ) p+q+1 HC═CH 2 ; wherein p and q independently are an integer from 0 to 15; and wherein the catalyst composition comprises: (I) a transition metal compound, a phosphine, a heteroatomic acid or heteroatomic acid derivative, and an acceptor; or (II) a phosphine transition metal compound complex, a heteroatomic acid or heteroatomic acid derivative, and an acceptor. 16. The process of claim 15 , wherein: the second normal alpha olefin comprises 1-hexene, 1-octene, 1-decene, 1-dodecene, 1-tetradecene, 1-hexadecene, 1-octadecene, or any combination thereof; and a molar ratio of the acceptor to the linear aldehyde is in a range from about 0.2:1 to about 1000:1. 17. The process of claim 16 , wherein the acceptor comprises an enone, an enamine, an enol, an enamide, or any combinations thereof. 18. The process of claim 16 , wherein: a molar yield of the second normal alpha olefin is at least about 50%, based on the linear aldehyde; the transition metal compound or the transition metal compound of the phosphine transition metal compound complex comprises an olefin rhodium alkoxide complex; and the heteroatomic acid or heteroatomic acid derivative comprises a carboxylic acid, an alcohol, a mineral acid, an ammonium salt, an amine, a thiol, or any combination thereof. 19. The process of claim 16 , wherein: the heteroatomic acid or heteroatomic acid derivative comprises benzoic acid or a substituted benzoic acid, or a salt or ester of benzoic acid or a substituted benzoic acid.
Cyclic compounds, e.g. cyclopentadienyls · CPC title
Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane · CPC title
Oxidation reactions, e.g. epoxidation, (di)hydroxylation, dehydrogenation and analogues · CPC title
by oxidation reactions with formation of hydroxy groups · CPC title
also containing elements or functional groups covered by B01J31/0201 - B01J31/0231 · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.